A Study of AZD2936 Anti-TIGIT/Anti-PD-1 Bispecific Antibody in Participants With Advanced or Metastatic NSCLC

RECRUITING

Research Site, Taipei

ACTIVE_NOT_RECRUITING

Research Site, Anderlecht

ACTIVE_NOT_RECRUITING

Research Site, Copenhagen

COMPLETED

Research Site, Melbourne

ACTIVE_NOT_RECRUITING

Research Site, Leuven

WITHDRAWN

Research Site, Taipei

RECRUITING

Research Site, Bangkok

RECRUITING

Research Site, Dijon

WITHDRAWN

Research Site, Baltimore

RECRUITING

Research Site, Chanthaburi

RECRUITING

Research Site, Fairfax

ACTIVE_NOT_RECRUITING

Research Site, Madrid

ACTIVE_NOT_RECRUITING

Research Site, Madrid

RECRUITING

Research Site, Toulouse

RECRUITING

Research Site, Taichung

RECRUITING

Research Site, Muang

RECRUITING

Research Site, Rochester

RECRUITING

Research Site, Kuala Lumpur

RECRUITING

Research Site, Chicago

RECRUITING

Research Site, Tainan City

WITHDRAWN

Research Site, Houston

WITHDRAWN

Research Site, Orange

RECRUITING

Research Site, Kuching

WITHDRAWN

Research Site, Singapore

ACTIVE_NOT_RECRUITING

Research Site, Chongqing

WITHDRAWN

Research Site, Wuhan

RECRUITING

Research Site, Chengdu

RECRUITING

Research Site, Porto Alegre

RECRUITING

Research Site, Florianópolis

RECRUITING

Research Site, Natal

RECRUITING

Research Site, Rio de Janeiro

RECRUITING

Research Site, São Paulo

RECRUITING

Research Site, Tbilisi

RECRUITING

Research Site, Kashiwa

RECRUITING

Research Site, Niigata

RECRUITING

Research Site, Sendai

RECRUITING

Research Site, Tokyo

RECRUITING

Research Site, Chisinau

ACTIVE_NOT_RECRUITING

Research Site, Groningen

ACTIVE_NOT_RECRUITING

Research Site, Leiden

COMPLETED

Research Site, Utrecht

RECRUITING

Research Site, Seoul

RECRUITING

Research Site, Seoul

RECRUITING

Research Site, Seoul

ACTIVE_NOT_RECRUITING

Research Site, Barcelona

RECRUITING

Research Site, Taichung

WITHDRAWN

Research Site, Leicester

WITHDRAWN

Research Site, Manchester